GBT
NVO

Grove Bank & Trust’s Novo Nordisk NVO Stock Holding History

Grove Bank & Trust’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$489K Sell
10,207
-353
-3% -$15.2K 0.05% 173
2026
Q1 		$388K Buy
10,560
+2,617
+33% +$124K 0.04% 194
2025
Q4 		$404K Buy
7,943
+6,783
+585% +$347K 0.05% 191
2025
Q3 		$64.4K Sell
1,160
-389
-25% -$22.8K 0.01% 387
2025
Q2 		$107K Sell
1,549
-615
-28% -$41.8K 0.01% 329
2025
Q1 		$150K Sell
2,164
-10,967
-84% -$906K 0.02% 275
2024
Q4 		$1.13M Sell
13,131
-181
-1% -$19.6K 0.16% 94
2024
Q3 		$1.59M Buy
13,312
+1,669
+14% +$223K 0.23% 79
2024
Q2 		$1.66M Buy
11,643
+840
+8% +$111K 0.27% 70
2024
Q1 		$1.39M Buy
10,803
+1,040
+11% +$124K 0.23% 75
2023
Q4 		$1.01M Buy
9,763
+4,976
+104% +$492K 0.19% 91
2023
Q3 		$435K Buy
+4,787
New +$422K 0.09% 151
2023
Q2 		– Sell
-138
Closed -$11K – 703
2023
Q1 		$11K Buy
138
+2
+1% +$142 ﹤0.01% 504
2022
Q4 		$9K Buy
+136
New +$7.97K ﹤0.01% 502
2016
Q3 		– Sell
-2,516
Closed -$68K – 267
2016
Q2 		$68K Hold
2,516
– – 0.06% 139
2016
Q1 		$68K Sell
2,516
-520
-17% -$13.9K 0.06% 141
2015
Q4 		$88K Buy
+3,036
New +$84K 0.08% 137

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Grove Bank & Trust's NVO Position: Q2 2026 in Review

Grove Bank & Trust reduced its Novo Nordisk (NVO) stake by 3.3% in Q2 2026, selling an estimated $15.2K and leaving 10,207 shares worth $489K. The position accounts for 0.05% of the portfolio, ranked #173.

Grove Bank & Trust first reported a position in NVO in Q4 2015 and has held it in 17 quarters since. The position peaked at $1.66M in Q2 2024. 344 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Grove Bank & Trust held 10,207 shares of Novo Nordisk worth $489K as of Q2 2026.
  • Grove Bank & Trust sold 353 Novo Nordisk shares in Q2 2026, an estimated $15.2K.
  • Novo Nordisk made up 0.05% of Grove Bank & Trust's portfolio in Q2 2026, its #173 holding.
  • Grove Bank & Trust first reported a position in Novo Nordisk in Q4 2015 and has held it in 17 quarters since.
  • Grove Bank & Trust's Novo Nordisk position peaked at $1.66M in Q2 2024.
  • 344 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.